Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 11-12, 1997, Pages 602-608

  Cao, Xuetao ^a   Chen, Guoyou ^a   He, Long ^a   Zhang, Weiping ^a   Yu, Yizhi ^a   Wang, Jianli ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene transfection; Interleukin 2; Interleukin 4; Interleukin 6; Melanoma cells

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; GENETIC TRANSFECTION; IMMUNOGENICITY; LYMPHOKINE ACTIVATED KILLER CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL CULTURE;

ANIMALS; CELL ADHESION; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GENES, MHC CLASS I; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKINS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; MELANOMA; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031441107     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050112     Document Type: Article

References (29)

1. Anichini A, Mortarini R, Supino R, Parmiani G (1990) Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability. Int J Cancer 46:508-515
2. Anichini A, Mortarini R, Alberti S, Mantovani A, Parmiani G (1993) T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int J Cancer 53:994-1001
3. Arienti F, Sule-Suso J, Melani C, Maccalli C, Belli F, Illeni MT, Anichini A, Cascinelli N, Colombo MP, Parmiani G (1994) Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum Gene Ther 5:1139-1150
4. Blankenstein T (1994) Increasing tumor immunogenicity by genetic modification. Eur J Cancer 30A: 1182-1187
5. Braakman E, Goedegebuure PS, Vreugdenhil RJ, Segal DM, Shaw S, Bolhuis RL (1990) ICAM-1 deficient melanoma cells are relatively resistant to CD3-mediated T-cell lysis. Int J Cancer 46:475-80
6. Cao X, Yu Y, Zhang W, Zhen L, Xu Z, Ye T (1995) Antimetastatic effects and its immunological mechanisms of IL-4 gene-transfected tumor vaccine in vivo. Chin J Microbiol Immunol 15:53-57
7. Cao X, Chen G, Zhang W, Yu Y, Ye T (1996) Enhanced efficacy of combination of IL-2 and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors. Gene Ther 3:421-426
8. Colombo M, Forni G (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 15:48-51
9. Elliott BE, Carlow DA, Rodricks A, Wade A (1989) Perspective on the role of MHC antigens in normal and malignant cell development. Adv Cancer Res 53:181-245
10. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397-403
11. Ferrini S, Sforzini S, Cambiaggi A, Poggi A, Meazza R, Canevari S, Colnaghi MI, Moretta L (1994) The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes. Int J Cancer 56:846-852
12. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E (1990) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217-1224
13. Garrido F, Cabrera T, ConCha A, Glew S, Ruiz-Cabello F, Stern PL (1993) Natural history of HLA expression during tumor development. Immunol Today 14:491-499
14. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM (1991) Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713-716
15. Gopas J, Rager-Zisman B, Bar-Eli M, Hammerling GJ, Segal S (1989) The relationship between MHC antigen expression and metastasis. Adv Cancer Res 53:89-115
16. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 90:2774-2778
17. Hoon DS, Hayashi Y, Morisaki T, Foshag LJ, Morton DE (1993) Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells. Cancer Immunol Immunother 37:378-384
18. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G (1989) De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86:641-644
19. Kageyama S, Tsomides T, Swulev Y, Eisen H (1995) Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T lymphocyte responses. J Immunol 60:397-403
20. Martz E, Davignon D, Kurzinger K, Springer TA (1982) The molecular basis for cytolytic T lymphocyte function: analysis with blocking monoclonal antibodies. Adv Exp Med Biol 146:447-165
21. Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, Blaese RM (1992) Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res 52:6020-6024
22. Olive D, Lopez M, Blaise D, Viens P, Stoppa AM, Brandely M, Mawas C, Mannoni P, Maraninchi D (1991) Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2. J Immunother 10:412-417
23. Paroli M, Carloni G, Franco A, De-Petrillo G, Alfani E, Perrone A, Barnba V (1994) Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction. Immunology 82:215-221
24. b gene. Proc Natl Acad Sci USA 85:4463-4467
25. Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA (1984) Lymphokine-activated killer cells: lysis of fresh syngenic natural killer -resistant murine tumor cells by lymphocyte cultured interleukin-2. Cancer Res 44:1946-1953
26. Schendel DJ, Gansbacher B (1993) Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous α-interferon treatment. Cancer Res 53:4020-4025
27. Schendel DL, Wank R, Dupont B (1979) Standardization of the human in vitro cell-mediated lympholysis technique. Tissue Antigens 13:112-120
28. Tepper RI, Pattengale PK, Leder P (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503-512
29. Wallich R, Bulbuc N, Hammerling GJ, Katzav S, Segal S, Feldman M (1985) Abrogation of metastatic properties of tumor cells by de novo expression of H-2k antigens following H-2 gene transfection. Nature 315:301-305